TABLE 1.

Measure of AAV RNA stability during a productive AAV-Ad coinfection^a

Time (h) posttreatment	AAV RNA stability (mean % remaining after treatment) ± SD)
	P5/19		P40
	Unspliced	Spliced	Unspliced	Spliced
0.5	102 ± 13	108 ± 15	91 ± 10	102 ± 15
3	92b	97b	79b	94b
5–6	84 ± 14	102 ± 17	71 ± 6	97 ± 22

^aAt 12 h after AAV-Ad coinfection, cells were treated with 40 mM actinomycin D for the periods indicated (see Materials and Methods for details). 

^bn = 2.